
Prevalence of epidermolytic toxin in clinical isolates of Staphylococcus aureus
Author(s) -
Joyce de Azavedo,
J. P. Arbuthnott
Publication year - 1981
Publication title -
journal of medical microbiology/journal of medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.91
H-Index - 117
eISSN - 1473-5644
pISSN - 0022-2615
DOI - 10.1099/00222615-14-3-341
Subject(s) - staphylococcus aureus , microbiology and biotechnology , toxin , serotype , biology , phage typing , immunodiffusion , enterotoxin , virology , bacteria , antibody , escherichia coli , immunology , gene , genetics
One hundred and sixteen strains of Staphylococcus aureus isolated from exfoliative skin lesions were screened for their ability to produce different serotypes of epidermolytic toxin (ET). Toxin production was assessed by immunodiffusion, analytical isoelectric focussing and examination for the Nikolsky sign in mice. Of 84 strains of phage group II, 72 (85.7%) were toxinogenic as were 10 of 32 (31.3%) non-group-II strains. The ability to produce ET serotypes A and B was not confined to a particular phage group.